维普期刊资源整合服务平台（V6.5）

130篇 您的检索式：作者名="Silverman SL"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	The clinical consequences of vertebral compres sion fracture显示文摘		1992	Bone1992，13，2：	1
2	Risk of new vertebral fracture in the year following a fracture显示文摘	Lindsay R Silverman SL Cooper C	2001	JAMA2001，285，3：	1
3	Efficacy ofbazedoxifene in reducing new vertebral fracture risk in postmenopausalwomen with osteoporosis: results from a 3-year, randomized, placebo-, and active controlled clinical trial显示文摘	Silverman SL Christiansen C Genant HK	2008	J Bone MinerRes2008，23，：	1
4	Risk of new vertebral fracture in the year following a fracture显示文摘	Lindsay R Silverman SL Cooper C	2001	JAMA2001，285，：	1
5	The clinical consequences of vertebral compression fracture显示文摘	Silverman SL	1992	Bone1992，13，2：	1
6	Risk of new vertebral fracture in the year following a fiacture显示文摘	Lindsay R Silverman SL Cooper C	2001	JAMA2001，285，3：	1
7	Risk of new vertebral frac- ture in the year following a fracture 显示文摘	Lindsay R Silverman SL Cooper C	2001	JAMA2001，285，：	1
8	Risk of new vertebral fracture in the year following a fracture 显示文摘	Lindsay R Silverman SL Cooper C	2001	JAMA2001，285，3：	1
9	New therapies for osteoporosis:zoledronic acid,bazedoxifene,and denosumab显示文摘	Silverman SL	2009	Curr Osteoporos Rep2009，7，3：	1
10	Risk of new vertebral fracture in the year following a fracture显示文摘	Lindsay R Silverman SL Cooper C	2001	JAMA2001，285，：	1
11	A systematic review of persistence and compliance with bisphosphonates for osteoporosis显示文摘	Cramcr JA Cold DT Silverman SL		0，，08：	1
12	Calcitonin 显示文摘	Silverman SL	2003	Endocrinol Metab Clin North Am2003，32，1：	1
13	A long-acting human growth hormone(Nutropin Depot) : efficacy and safety following two years of trealrnent in children with growth hormone deficiency显示文摘	Silverman BL Blethen SL Reiter EO	2002	J Pediatr Endocrinol Metab2002，15，2：	1
14	The clinical consequences of vertebral compression fracture 显示文摘	Silverman SL	1992	Bone1992，13，2：	1
15	Risk of new vertebral fracture in the year following a fracture显示文摘	Lindsay R Silverman SL Cooper C	2001	JAM/k2001，285，3：	1
16	Use of FRAX -based fracture risk assessments to identify patients who will benefit from osteoporosis therapy显示文摘	Silverman SL Komm BS Mirkin S	2014	Maturitas2014，79，3：	1
17	Anabolic therapies显示文摘	Lane NE Silverman SL	2010	Curr Os- teoporos Rep2010，8，1：	1
18	Risk of new vertebral fracture in the year fol owing a fracture显示文摘	Lindsay R Silverman SL Cooper C		0，，：	1
19	A sys tematic review of persistence and compliance with bisphosphonates for osteoporosis显示文摘	Cramer JA Gold DT Silverman SL	2007	Osteoporosis International2007，18，8：	1
20	New therapies for osteoporosis: zoledronic acid, bazedoxifene and denosumab显示文摘	Silverman SL	2009	Curr Osteoporos Rep2009，7，3：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示